Home › Compare › WLDFF vs JNJ

WLDFF vs JNJ: Dividend Comparison 2026

WLDFF yields 20000000.00% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 WLDFF wins by $4.875981653489057e+49M in total portfolio value
10 years
WLDFF
WLDFF
● Live price
20000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.875981653489057e+49M
Annual income
$48,759,336,949,911,260,000,000,000,000,000,000,000,000,000,000,000,000,000.00
Full WLDFF calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — WLDFF vs JNJ

📍 WLDFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodWLDFFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, WLDFF + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
WLDFF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

WLDFF
Annual income on $10K today (after 15% tax)
$1,700,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$41,445,436,407,424,570,000,000,000,000,000,000,000,000,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, WLDFF beats the other by $41,445,436,407,424,570,000,000,000,000,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of WLDFF + JNJ for your $10,000?

WLDFF: 50%JNJ: 50%
100% JNJ50/50100% WLDFF
Portfolio after 10yr
$2.4379908267445285e+49M
Annual income
$24,379,668,474,955,630,000,000,000,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
100.00%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

WLDFF
No analyst data
Altman Z
-0.6
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

WLDFF buys
0
JNJ buys
0
No recent congressional trades found for WLDFF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricWLDFFJNJ
Forward yield20000000.00% ✓2.14%
Annual dividend / share$2.00$5.20 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28% ✓
Portfolio after 10y$4.875981653489057e+49M$30.5K ✓
Annual income after 10y$48,759,336,949,911,260,000,000,000,000,000,000,000,000,000,000,000,000,000.00 ✓$4,749.88
Total dividends collected$4.875978515990276e+49M$15.6K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: WLDFF vs JNJ ($10,000, DRIP)

YearWLDFF PortfolioWLDFF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$2,000,010,700$2,000,000,000.00$10,594$274.49+$2000.00M → WLDFF
2$373,835,915,712,384$373,833,775,700,934.50$11,294$360.69+$373835915.70M → WLDFF
3$65,304,953,364,964,970,000$65,304,553,360,535,160,000.00$12,133$476.91+$65304953364964.96M → WLDFF
4$10,661,728,832,755,500,000,000,000$10,661,658,956,455,399,000,000,000.00$13,156$635.42+$10661728832755499008.00M → WLDFF
5$1,626,767,783,781,495,000,000,000,000,000$1,626,756,375,731,643,800,000,000,000,000.00$14,432$854.61+$1.626767783781495e+24M → WLDFF
6$231,974,330,054,625,100,000,000,000,000,000,000$231,972,589,413,096,470,000,000,000,000,000,000.00$16,056$1,162.76+$2.319743300546251e+29M → WLDFF
7$30,915,106,403,922,057,000,000,000,000,000,000,000,000$30,914,858,191,388,900,000,000,000,000,000,000,000,000.00$18,175$1,604.53+$3.0915106403922057e+34M → WLDFF
8$3,850,507,985,839,278,000,000,000,000,000,000,000,000,000,000$3,850,474,906,675,425,000,000,000,000,000,000,000,000,000,000.00$21,009$2,252.68+$3.8505079858392777e+39M → WLDFF
9$448,210,261,035,314,200,000,000,000,000,000,000,000,000,000,000,000$448,206,140,991,769,400,000,000,000,000,000,000,000,000,000,000,000.00$24,911$3,229.73+$4.4821026103531426e+44M → WLDFF
10$48,759,816,534,890,570,000,000,000,000,000,000,000,000,000,000,000,000,000$48,759,336,949,911,260,000,000,000,000,000,000,000,000,000,000,000,000,000.00$30,458$4,749.88+$4.875981653489057e+49M → WLDFF

WLDFF vs JNJ: Complete Analysis 2026

WLDFF — Stock

Wildflower Brands Inc. develops, designs, and sells branded products in the cannabis in Washington and California. It offers a line of hemp derived CBD+ wellness products, including CBD based topicals, soaps, tinctures, capsules, and vaporizers. The company also provides bundle box kit. The company offers its products online and through retailers. The company was formerly known as Wildflower Marijuana Inc. and changed its name to Wildflower Brands Inc. in April 2018. Wildflower Brands Inc. is headquartered in Vancouver, Canada.

Full WLDFF Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this WLDFF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

WLDFF vs SCHDWLDFF vs JEPIWLDFF vs OWLDFF vs KOWLDFF vs MAINWLDFF vs ABBVWLDFF vs MRKWLDFF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.